http://www.RealHealthAnswer… – Dr. Mayfield on cancer & heart disease cause & prevention – today’s foods and why nutrient & antioxidant rich fruits like acai
CHART: http://bit.ly/chocolateVSacai … So? It’s your turn to do some work! COMMENT! =P http://jbni.us is the producer of this video and Noagin, the Super-Antioxidant containing astaxanthin, zeaxa…
The power of Alkaline Water! Texas State University is about to release results of a study that could mean a new way to fight cancer. Don’t run out and buy alkaline water yet, this testing was done in vitrio and with alka-v6/alkav6 only.
News 8’s Todd Boatwright has more on the two Texas State researchers’ findings.
The news comes as the number of breast cancer patients in Central Texas alone is expected to reach 900 this year.
Dr. Dhiraj Vattem, a professor in the Department of Family and Consumer Sciences, and Texas State Department of Agriculture Chair Dr. Reed Richardson co-investigated the new compound.
“We have a product we’ve been testing in the laboratory. All we’ve done so far is in vitro testing, which is artificial settings outside the organism,” Dr. Richardson said. “It is a compound that looks very effective in changing some of the metabolic pathways that are responsible for the cancer to either attach or grow.”
Dr. Richardson said that with the particular compound (alkav6) they have been testing, results were very consistent.
“It’s a silicon-based compound, and we use this at different levels to test these different systems, within cancer cells, as well as the HIV virus,” Dr. Richardson said. “We got real promise and results from that.”
Texas State researchers and Orizon Research Institute will present their current findings in a press conference at 2 p.m. Wednesday on the second floor of the Agricultural Building on the Texas State Campus.
For cancer, in vitro tests, the compound (alkav6) prevented cancerous cells from attaching to other cells, which slows down cancerous cells’ growth rate, Dr. Richardson said. The compound also reduced harmful mutations in the DNA and increased the likelihood of apoptosis, or programmed cell death. Finally the compound stimulated anti-oxidant enzymes responsible for some of the metabolic pathways.
“We measured a lot of different things in vitro, but they all got nice responses from the standpoint of pointing us toward a direction for a mode of action on this product,” he said. “It’s very important to say, that second phase, where we go in vivo, inside organisms within organisms’ systems, is the definitive step.”
The data from the in vivo studies is expected to be published later this year.
